News

Keryx Biopharmaceuticals has reached an agreement with the FDA regarding a Special Protocol Assessment (SPA) on the design of a phase 3 clinical program for Zerenex (ferric citrate).

Particle Sciences (PSI) has entered into an agreement with Horiba Scientific. As per the agreement, Particle Sciences is expected to acquire Horiba Raman/Particle Characterisation System with guaranteed hardware

Response Biomedical has received a Notice of Allowance from the European Patent Office for the patent entitled, ‘Sensitive Immunochromatographic Assay’, referred to as the ‘Fong Patent’. The patent

As per the agreement, Genetic Technologies will become the distributor in Australia, Indonesia, Malaysia, the Philippines, Singapore and Thailand. ResponseDX tests are proprietary PCR-based tests used to analyze

MabCure has signed a clinical research agreement with the Ramathibodi Hospital, Mahidol University in Bangkok, Thailand. The study aims to evaluate MabCure’s panel of anti-ovarian MAbs in diagnosing

Luitpold Pharmaceuticals, a US subsidiary of Daiichi Sankyo, and PharmaForce have announced that PharmaForce has been acquired by Luitpold. The FTC cleared the transaction under the Hart-Scott-Rodino Antitrust

Cargill has reached a manufacturing agreement with Westfeeds to buy billings feed mill and property. Officials from both companies anticipate that the sale will close by mid-February 2010.

Under the terms of the agreement, MRS will incorporate ‘risk flags’ for hereditary breast cancer risk in their breast cancer tracking software. This will enable medical professionals at

LifeVantage Corporation (LifeVantage) has received formal approval from the Mexican government to launch Protandim in Mexico. The company said that the initial shipments have cleared customs and Protandim